Electronic brachytherapy as adjuvant therapy for early stage breast cancer: A retrospective analysis

OncoTargets and Therapy

Volumn 4, Issue , 2011, Pages 13-20

  Dooley, William C ^a   Wurzer, James C ^b   Megahy, Mohamed ^c   Schreiber, Gary ^d   Roy, Tapan ^e   Proulx, Gary ^f   Laduzinsky, Susan ^g   Lane, Steven ^h   Dalzell, James ⁱ   Dowlatshahi, Kambiz ^j   Simmons, Dwelvin ^k   Thropay, John P ^l   Ahuja, Harish ^m   Beitsch, Peter ⁿ   Holt, Randall W ^o   Lee, Charles A ^p  

^a UNIVERSITY OF OKLAHOMA HEALTH SCIENCES CENTER   (United States)

^b AtlantiCare   (United States)

^c Maryville Oncology   (United States)

^d SWEDISH COVENANT HOSPITAL   (United States)

^e Cape Girardeau Physician Associates   (United States)

^f Exeter Hospital   (United States)

^g St Elizabeth's Medical Center   (United States)

^h Brockton Hospital   (United States)

ⁱ Nazha Cancer Center   (United States)

^j RUSH UNIVERSITY MEDICAL CENTER   (United States)

^k Florida Radiation Oncology Group   (United States)

^l Beverly Oncology/Imaging Centers   (United States)

^m Aspirus Cancer Center   (United States)

ⁿ Dallas Surgical Group   (United States)

^o Pacific Crest Medical Physics   (United States)

^p Gulf Coast Cancer Treatment Center   (United States)

more..

Author keywords

Breast cancer; Electronic brachytherapy; Radiation therapy

Indexed keywords

IRIDIUM 192;

ADULT; AGED; BRACHYTHERAPY; BREAST CANCER; BREAST TENDERNESS; CANCER RISK; CANCER STAGING; CONTROLLED STUDY; DERMATITIS; DOSIMETRY; EARLY CANCER; ERYTHEMA; FAT NECROSIS; FATIGUE; FIBROSIS; FOLLOW UP; HUMAN; HYPERPIGMENTATION; HYPOPIGMENTATION; INFECTION; MAJOR CLINICAL STUDY; OUTCOME ASSESSMENT; PRURITUS; RADIATION EQUIPMENT; RADIATION RESPONSE; RASH; RETROSPECTIVE STUDY; REVIEW; SEROMA; SKIN INDURATION; TELANGIECTASIA; TUMOR VOLUME;

EID: 79953150053     PISSN: 11786930     EISSN: None     Source Type: Journal    
DOI: 10.2147/OTT.S15297     Document Type: Review

References (29)

1. National Cancer Institute Website. 2010. Available from: http://www. cancer.gov/cancertopics/types/breast. Accessed Jun 16 2010.
2. National Comprehensive Cancer Network Website. 2010. Available from: http://www.nccn.org/index.asp. Accessed Mar 3 2010.
3. Pawlik TM, Buchholz TA, Kuerer HM. The biologic rational for and emerging role of accelerated partial breast irradiation for breast cancer. J Am Coll Surg. 2004;199(3):479-492.
4. Schroen AT, Brenin DR, Kelly MD, Knaus WA, Slingluff CL Jr. Impact of patient distance to radiation therapy on mastectomy use in early-stage breast cancer patients. J Clin Oncol. 2005;23(28): 7074-7080.
5. Athas WF, Adams-Cameron M, Hunt WC, Amir-Fazli A, Key CR. Travel distance to radiation therapy and receipt of radiotherapy following breast conserving surgery. J Natl Cancer Inst. 2000;92(3): 269-271.
6. Dickler A, Kirk MC, Seif N, et al. A dosimetric comparison of MammoSite high-dose-rate brachytherapy and Xoft Axxent electronic brachytherapy. Brachytherapy. 2007;6(2):164-168.
7. Mehta VK, Algan O, Griem KL, et al. Experience with an electronic brachytherapy technique for intracavitary accelerated partial breast irradiation. Am J Clin Oncol. 2010;33(4):327-335.
8. Mille MM, Xu G, Rivard MJ. Comparison of organ doses for patients undergoing balloon brachytherapy of the breast with HDR 192-Ir or electronic sources using monte carlo simulations in a heterogeneous human phantom. Med Phys. 2010;37(2):662-671.
9. Vicini FA, Baglan KL, Kestin LL, et al. Accelerated treatment of breast cancer. J Clin Oncol. 2001;19(7):1993-2001.
10. King TA, Bolton JS, Kuske RR, Fuhrman GM, Scroggins TG, Jiang XZ. Long term results of wide-field brachytherapy as the sole method of radiation therapy after segmental mastectomy for T(is,1,2) breast cancer. Am J Surg. 2000;180(4):299-304.
11. Wazer DE, Berle L, Graham R, et al. Preliminary results of a phase I/II study of HDR brachytherapy alone for T1/T2 breast cancer. Int J Radiat Oncol Biol Phys. 2002;53(4):889-897.
12. Vicini, FA, Kestin L, Chen P, Benitez P, Goldstein NS, Martinez A. Limited-field radiation therapy in the management of early-stage breast cancer. J Natl Cancer Inst. 2003;95(16):1205-1211.
13. Dickler A, Kirk MC, Coon A, et al. A dosimetric comparison of Xoft Axxent electronic brachytherapy and iridium-192 high-dose-rate brachytherapy in the treatment of endometrial cancer. Brachytherapy. 2008;7(4):351-354.
14. Rivard MJ, Davis SD, DeWerd LA, Rusch TW, Axelrod S. Calculated and measured brachytherapy dosimetry parameters in water for the Xoft Axxent X-Ray Source: an electronic brachytherapy. Med Phys. 2006;33(11):4020-4032.
15. Beitsch, PD, Patel RR, Lorenzetti JD, et al. Post-surgical treatment of early-stage breast cancer with electronic brachytherapy: an intersociety, multicenter brachytherapy trial. Onco Targets Ther. 2010; 3: 211-218.
16. Keisch M, Vicini F, Kuske RR, et al. Initial clinical experience with the MammoSite breast brachytherapy applicator in women with early-stage breast cancer treated with breast-conserving therapy. Int J Radiat Oncol Biol Phys. 2003;55(2):289-293.
17. Haley M, Beriwal S, Heron DE, et al. MammoSite accelerated partial breast irradiation: a single-institution outcomes analysis with two years of follow-up. Brachytherapy. 2009;8(1):9-13.
18. Chao KK, Vicini FA, Wallace M, et al. Analysis of treatment efficacy, cosmesis, and toxicity using the MammoSite breast brachytherapy catheter to deliver accelerated partial-breast irradiation: the William Beaumont hospital experience. Int J Radiat Oncol Biol Phys. 2007; 69(1):32-40.
19. Richards GM, Berson AM, Resigno J, et al. Acute toxicity of high dose rate brachytherapy with the MammoSite applicator in patients with early-stage breast cancer. Ann Surg Oncol. 2004;11(8):739-746.
20. Zannis V, Beitsch PD, Vicini F, et al. Descriptions and outcomes of insertion techniques of a breast brachytherapy balloon catheter in 1,403 patients enrolled in the American Society of Breast Surgeons MammoSite breast brachytherapy registry trial. Am J Surg. 2005; 190(4):530-538.
21. Wazer DE, Kaufman S, Cuttino L, DiPetrillo T, Arthur DW. Accelerated partial breast irradiation: an analysis of variables associated with late toxicity and long-term cosmetic outcome after high-dose-rate interstitial brachytherapy. Int J Radiat Oncol Biol Phys. 2006;64(2):489-495.
22. Dickler A, Seif N, Kirk MC, et al. A dosimetric comparison of MammoSite and ClearPath high-dose-rate breast brachytherapy devices. Brachytherapy. 2009;8(1):14-18.
23. Radiation Therapy Oncology Group. National Surgical Adjuvant Breast and Bowel Project (NSABP) protocol B-39 and Radiation Therapy Oncology Group (RTOG) protocol 0413. 2005 Mar 21. http://www. rtog.org/members/protocols/0413/0413.pdf. Accessed Oct 22 2010.
24. Vicini FA, Beitsch PD, Quiet CA, et al. Three-year analysis of efficacy, cosmesis, and toxicity by the American Society of Breast Surgeons MammoSite breast brachytherapy registry trial in patients with accelerated partial breast irradiation (APBI). Cancer. 2008;112(4): 758-766.
25. Vicini FA, Beitsch PD, Quiet CA, et al. First analysis of patient demographics, technical reproducibility, cosmesis, and early toxicity: results of the American Society of Breast Surgeons MammoSite breast brachytherapy registry trial. Cancer. 2005;104(6):1138-1148.
26. Ivanov O, Dickler A, Lum BYF, Pellicane JV, Francescatti DS. Twelve-month follow-up results of a trial utilizing Axxent electronic brachytherapy to deliver intraoperative radiation therapy for early-stage breast cancer. Ann Surg Oncol. 2010 Aug 25. [Epub ahead of print].
27. Vaidya JS, Joseph DJ, Tobias JS, et al. Targeted intraoperative radiotherapy versus whole breast radiotherapy for breast cancer (TARGIT-A trial): an international, prospective, randomized, non-inferiority phase 3 trial. Lancet. 2010;376(9735):91-102.
28. Marks LB, Yu X, Prosnitz RG, et al. The incidence and functional consequences of RT-associated cardiac perfusion defects. Int J Radiat Oncol Biol Phys. 2005;63(1):214-223.
29. Garza R, Albuquerque K, Sethi A. Lung and cardiac tissue doses in left breast cancer patients treated with single-source breast brachytherapy compared to external beam tangent fields. Brachytherapy. 2006;5(4): 235-238.